Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Zhengshi Lin"'
Autor:
Zhiqi Zeng, Yong Liu, Wenxiang Jin, Jingyi Liang, Jinbin Chen, Ruihan Chen, Qianying Li, Wenda Guan, Lixi Liang, Qiubao Wu, Yuanfang Lai, Xiaoyan Deng, Zhengshi Lin, Chitin Hon, Zifeng Yang
Publikováno v:
Infectious Diseases of Poverty, Vol 13, Iss 1, Pp 1-10 (2024)
Abstract Background Non-pharmaceutical measures and travel restrictions have halted the spread of coronavirus disease 2019 (COVID-19) and influenza. Nonetheless, with COVID-19 restrictions lifted, an unanticipated outbreak of the influenza B/Victoria
Externí odkaz:
https://doaj.org/article/eecf368ee7f448c98a49356ba294fa3f
Autor:
Zhiqi Zeng, Qianying Li, Hua Guo, Yong Liu, Lixi Liang, Yuanfang Lai, Yi Fang, Lei Li, Qiuting Xue, Yangqing Zhan, Zhengshi Lin, Wenda Guan, Zifeng Yang
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
BackgroundAccurate detection of influenza virus in clinical samples requires correct execution of all aspects of the detection test. If the viral load in a sample is below the detection limit, a false negative result may be obtained. To overcome this
Externí odkaz:
https://doaj.org/article/707b2343adb643b88c6727b92a9aaa2b
Autor:
Yang Wang, Chunguang Yang, Yong Liu, Jiawei Zhang, Wei Qu, Jingyi Liang, Chuanmeizi Tu, Qianyi Mai, Kailin Mai, Pei Feng, Wenjing Huang, Zhengshi Lin, Chitin Hon, Zifeng Yang, Weiqi Pan
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 4, Pp 826-828 (2024)
In 2022, we assessed avian influenza A virus subtype H5N6 seroprevalence among the general population in Guangdong Province, China, amid rising numbers of human infections. Among the tested samples, we found 1 to be seropositive, suggesting that the
Externí odkaz:
https://doaj.org/article/b869fe5e3e7b4aa498ea7c09c4fca73b
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Reducing current clinical symptoms and the risks of future exacerbations is the main goal of stable COPD management. Traditional Chinese medicine has unique advantages in chronic disease management. YuPingFeng (YPF), as a classica
Externí odkaz:
https://doaj.org/article/d75fc8cb659044548503e4b661853c42
Autor:
Yangqing Zhan, Zhengshi Lin, Jingyi Liang, Ruilin Sun, Yueping Li, Bingliang Lin, Fangqi Ge, Ling Lin, Hongzhou Lu, Liang Su, Tianxin Xiang, Hongqiu Pan, Chaolin Huang, Ying Deng, Furong Wang, Ruhong Xu, Dexiong Chen, Ping Zhang, Jianlin Tong, Xifu Wang, Qingwei Meng, Zhigang Zheng, Shuqiang Ou, Xiaoyun Guo, Herui Yao, Tao Yu, Weiyang Li, Yu Zhang, Mei Jiang, Zhonghao Fang, Yudi Song, Ruifeng Chen, Jincan Luo, Changyuan Kang, Shiwei Liang, Haijun Li, Jingping Zheng, Nanshan Zhong, Zifeng Yang, Huang Yanming, M.M, Dong Haiping, M.D., Jinlin Hou, M.M, Shao Lei, M.D., Li Xiaoguang, M.D., Gao Yan, M.M.
Publikováno v:
EClinicalMedicine, Vol 67, Iss , Pp 102359- (2024)
Summary: Background: Leritrelvir is a novel α-ketoamide based peptidomimetic inhibitor of SARS-CoV-2 main protease. A preclinical study has demonstrated leritrelvir poses similar antiviral activities towards different SARS-CoV-2 variants compared wi
Externí odkaz:
https://doaj.org/article/47dbfffb279a4d67b276d3a4042f438c
Autor:
Jing Dai, Duo Xu, Chao Yang, Huan Wang, Dehui Chen, Zhengshi Lin, Shuyan Qiu, Li Zhang, Xiao Li, Xingui Tian, Qian Liu, Yujun Cui, Rong Zhou, Wenkuan Liu
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 2 (2023)
Coxsackievirus B4 (CVB4) has one of the highest proportions of fatal outcomes of other enterovirus serotypes. However, the pathogenesis of severe respiratory disease caused by CVB4 infection remains unclear. In this study, 3 of 42 (7.2%, GZ-R6, GZ-R7
Externí odkaz:
https://doaj.org/article/d50b86ac1a6d4d34b7bac8b2c8f1b642
Autor:
Zhiqi Zeng, Tong Wu, Zhijie Lin, Lei Luo, Zhengshi Lin, Wenda Guan, Jingyi Liang, Minfei Yu, Peikun Guan, Wei He, Zige Liu, Guibin Lu, Peifang Xie, Canxiong Chen, Eric H. Y. Lau, Zifeng Yang, Chitin Hon, Jianxing He
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract China detected the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with Delta variant in May 2021. We assessed control strategies against this variant of concern. We constructed a robust transmission mode
Externí odkaz:
https://doaj.org/article/b7da6adfe05a4fd9b4a9e8b1161662fe
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/aadb266eecf34944b05426cb3123a581
Autor:
Wenfeng Cai, Zifeng Yang, Jingyi Liang, Zhengshi Lin, Yu Ma, Chun Chen, Yan Li, Yongming Li, Zhitong Mai, Kailin Mai, Xuetao Kong, Xingyi Liang, Qianying Li, Chuanmeizi Tu, Canxiong Chen, Chitin Hon, Pengzhe Qin, Ke Li, Xiaoning Li, Yutian Miao, Xuexing Liu, Wenda Guan, Zhiqi Zeng, Wanli Qiu, Wei He, Lin Zhang, Zhicong Yang, Nanshan Zhong
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
IntroductionSARS-CoV-2 has ravaged the world and undergone multiple mutations during the course of the COVID-19 pandemic. On 7 April 2022, an epidemic caused by SARS-CoV-2 Omicron (BA.2) variant broke out in Guangzhou, China, one of the largest trans
Externí odkaz:
https://doaj.org/article/c6b20199321d4858b7cbb540b3fa22b4
Autor:
Zhiqi Zeng, Wenda Guan, Yong Liu, Zhengshi Lin, Wenhua Liang, Jingyi Liang, Bingqian Chen, Tong Wu, Yutao Wang, Chunguang Yang, Qiubao Wu, Zhitong Mai, Jinchao Zhou, Junhou Zhou, Zhoulang Wang, Zhijie Lin, Chaohui Hu, Chunqiu Wu, Pengyuan Zhu, Canxiong Chen, Nanshan Zhong, Eric H. Y. Lau, Chitin Hon, Yaoming Liang, Zifeng Yang, Jianxing He
Publikováno v:
Frontiers in Microbiology, Vol 12 (2022)
China implemented stringent non-pharmaceutical interventions (NPIs) in spring 2020, which has effectively suppressed SARS-CoV-2. In this study, we utilized data from routine respiratory virus testing requests from physicians and examined circulation
Externí odkaz:
https://doaj.org/article/cdeb2fe9e4f749a28e1d6dfe6ce3f38b